Pulmonary cavitary disease due to Mycobacterium xenopi

Non-tuberculous mycobacteria are a significant cause of pulmonary infections worldwide and can be clinically challenging. Mycobacterium xenopi (M. xenopi) has a low pathogenicity and usually requires immunosuppression or lung diseases. We describe herein a scarce case of pulmonary cavitary disease a...

Full description

Bibliographic Details
Main Authors: Yousri Ben Abdallah, Nabil Belfeki, Timothée Klopfenstein, Souheil Zayet
Format: Article
Language:English
Published: Elsevier 2022-03-01
Series:Infectious Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772431X21000034
_version_ 1797345876227653632
author Yousri Ben Abdallah
Nabil Belfeki
Timothée Klopfenstein
Souheil Zayet
author_facet Yousri Ben Abdallah
Nabil Belfeki
Timothée Klopfenstein
Souheil Zayet
author_sort Yousri Ben Abdallah
collection DOAJ
description Non-tuberculous mycobacteria are a significant cause of pulmonary infections worldwide and can be clinically challenging. Mycobacterium xenopi (M. xenopi) has a low pathogenicity and usually requires immunosuppression or lung diseases. We describe herein a scarce case of pulmonary cavitary disease attributed to M. xenopi in a 57-year-old Caucasian patient with underlying structural lung disease successfully treated with rifampicin, ethambutol, clarithromycin, and amikacin.
first_indexed 2024-03-08T11:25:04Z
format Article
id doaj.art-cc77442a976348c088de12917d72f8b1
institution Directory Open Access Journal
issn 2772-431X
language English
last_indexed 2024-03-08T11:25:04Z
publishDate 2022-03-01
publisher Elsevier
record_format Article
series Infectious Medicine
spelling doaj.art-cc77442a976348c088de12917d72f8b12024-01-26T05:35:51ZengElsevierInfectious Medicine2772-431X2022-03-01116366Pulmonary cavitary disease due to Mycobacterium xenopiYousri Ben Abdallah0Nabil Belfeki1Timothée Klopfenstein2Souheil Zayet3Pneumology Department, Hôpital Nord Franche-Comté (HNFC), Belfort, FranceInternal Medicine Department, Groupe Hospitalier Sud Ile de France, Melun, FranceInfectious Diseases Department, Hôpital Nord Franche-Comté (HNFC), Belfort, FranceInfectious Diseases Department, Hôpital Nord Franche-Comté (HNFC), Belfort, France; Corresponding author.Non-tuberculous mycobacteria are a significant cause of pulmonary infections worldwide and can be clinically challenging. Mycobacterium xenopi (M. xenopi) has a low pathogenicity and usually requires immunosuppression or lung diseases. We describe herein a scarce case of pulmonary cavitary disease attributed to M. xenopi in a 57-year-old Caucasian patient with underlying structural lung disease successfully treated with rifampicin, ethambutol, clarithromycin, and amikacin.http://www.sciencedirect.com/science/article/pii/S2772431X21000034Mycobacterium xenopiNon-tuberculous mycobacteriaCOPDPulmonary cavitary disease
spellingShingle Yousri Ben Abdallah
Nabil Belfeki
Timothée Klopfenstein
Souheil Zayet
Pulmonary cavitary disease due to Mycobacterium xenopi
Infectious Medicine
Mycobacterium xenopi
Non-tuberculous mycobacteria
COPD
Pulmonary cavitary disease
title Pulmonary cavitary disease due to Mycobacterium xenopi
title_full Pulmonary cavitary disease due to Mycobacterium xenopi
title_fullStr Pulmonary cavitary disease due to Mycobacterium xenopi
title_full_unstemmed Pulmonary cavitary disease due to Mycobacterium xenopi
title_short Pulmonary cavitary disease due to Mycobacterium xenopi
title_sort pulmonary cavitary disease due to mycobacterium xenopi
topic Mycobacterium xenopi
Non-tuberculous mycobacteria
COPD
Pulmonary cavitary disease
url http://www.sciencedirect.com/science/article/pii/S2772431X21000034
work_keys_str_mv AT yousribenabdallah pulmonarycavitarydiseaseduetomycobacteriumxenopi
AT nabilbelfeki pulmonarycavitarydiseaseduetomycobacteriumxenopi
AT timotheeklopfenstein pulmonarycavitarydiseaseduetomycobacteriumxenopi
AT souheilzayet pulmonarycavitarydiseaseduetomycobacteriumxenopi